Speakers
Maria Deli
Maria Deli, Scientific Adviser, Group Leader
Biological Research Centre, Szeged, Hungary
Katherine Deng
Principal Scientist
AbbVie
Day Two
Wednesday June 30, 2021
4:00 pm | Live Q&A with Your Expert Speakers
2:30 pm | In Vitro BBB Models for Biologic Drug Screening
Sungwon An
Director
ABL Bio
Day One
Tuesday June 29 2021
1:00 pm | Live Q&A with Your Expert Speakers
12:00 pm | Application of Grabody B, an IGF1R-Mediated BBB Shuttle
Steve Stice
CSO
Aruna Bio, Inc
Day One
Tuesday June 29 2021
6:10 pm | Live Q&A with Your Expert Speakers
5:10 pm | Neural Extracellular Vesicle Role in Noninvasive CNS Drug Delivery
Anna Jezierski
Research Officer, Human Health Therapeutics Research Centre
National Research Council of Canada
Day Two
Wednesday June 30, 2021
4:00 pm | Live Q&A with Your Expert Speakers
Danica Stanimirovic
Director, Translational Bioscience, Human Health Therapeutics Research Centre
National Research Council of Canada
Day One
Tuesday June 29 2021
8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them
Will Costain
Senior Research Officer, Human Health Therapeutics Research Centre
National Research Council of Canada
Day One
Tuesday June 29 2021
1:00 pm | Live Q&A with Your Expert Speakers
11:30 am | Enabling Peripheral Enzyme Replacement Therapy to Alleviate CNS Pathology in Lysosomal Storage Disease
Jean-François Ghersi-Egea
Research Director
INSERM
Day One
Tuesday June 29 2021
4:40 pm | Targeting the “Other” Blood-Brain Barriers for Cerebral Drug Delivery
6:10 pm | Live Q&A with Your Expert Speakers
Raleigh Linville
Post-doc, Searson Group, Johns Hopkins
Institute for NanoBioTechnology
Day Two
Wednesday June 30, 2021
4:00 pm | Live Q&A with Your Expert Speakers
3:30 pm | State-of-the-Art Tissue-Engineered Models of the Human Blood-Brain Barrier
Susan Rosenbaum
Founder, Chairman, CEO
Lauren Sciences LLC
Day Two
Wednesday June 30, 2021
1:00 pm | Live Q&A with Your Expert Speakers
11:30 am | The Brain Delivery Trifecta: Triple-Targeted, Non-Invasive CNS Platform for Non-BBB Penetrants
Karin Otte
Principal Scientist
Merck
Day One
Tuesday June 29 2021
6:10 pm | Live Q&A with Your Expert Speakers
5:40 pm | CNS Drug Discovery: A Strategy to Develop Freely Penetrant CNS Drugs
Jonathan Sugam
Associate Principal Scientist, Neuroscience Discovery
Merck
Day One
Tuesday June 29 2021
8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them
Kirk Tanner
Chief Scientific Officer
National Brain Tumor Society (NBTS)
Day Two
Wednesday June 30, 2021
9:40 am | Learning from Oncology – Exploring Delivery of Therapeutics to CNS Tumours
10:10 am | Live Q&A with your Expert Speakers
Moein Moghimi
Professor of Pharmaceutics & Nanomedicine Newcastle University
Newcastle University
Day Two
Wednesday June 30, 2021
1:00 pm | Live Q&A with Your Expert Speakers
12:30 pm | Nanoligand Carriers: A Versatile Self-Assembly Platform for the Delivery of Macromolecular Therapeutics to the Brain
Manuel Sanchez-Felix
Senior Fellow, Novel Delivery Technologies
Novartis Institute for Biomedical Research
Day One
Tuesday June 29 2021
8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them
Pawel Stocki
Director of Research
Ossianix
Day One
Tuesday June 29 2021
1:00 pm | Live Q&A with Your Expert Speakers
11:00 am | Blood-Brain Barrier Delivery in Non-Human Primates by Single Domain VNAR Antibodies to TfR1
Felix Schumacher
Program Leader Targeted Therapeutics
Roche
Day One
Tuesday June 29 2021
8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them
Peter Westenskow
Senior Principal Scientist & Section Head
Roche
Day One
Tuesday June 29 2021
6:10 pm | Live Q&A with Your Expert Speakers
4:10 pm | BBB-Improving Strategies to Prevent Retinopathies
Stina Syvänen
Associate Professor
Uppsala University
Day One
Tuesday June 29 2021
1:00 pm | Live Q&A with Your Expert Speakers
12:30 pm | Bispecific Brain-Penetrating Antibodies – New Possibilities for In Vivo Brain Imaging
Emmanuelle Canet Soulas
Professor of Physiology, University of Lyon, CarMeN lab
INSERM
Day Two
Wednesday June 30, 2021
1:00 pm | Live Q&A with Your Expert Speakers
12:00 pm | Exploring Applications of PET-MRI Nanoparticles for Multimodal Imaging of the BBB
José Obeso
Professor of Neurology
University of Navarra
Day Two
Wednesday June 30, 2021
10:10 am | Live Q&A with your Expert Speakers
9:10 am | Opening the BBB in Parkinson´s Disease and Other Neurodegenerations: A Window into Disease Modification
Raphael Lis
Assistant Professor
Weill Cornell Medical College
Day Two
Wednesday June 30, 2021
4:00 pm | Live Q&A with Your Expert Speakers
2:00 pm | Human Induced Pluripotent Stem Cell-derived Brain Endothelial Cells: Current Controversies and Progress
Nathalie Agar
Associate Professor of Neurosurgery & Radiology
Harvard Medical School
Michelle Erickson
Research Assistant Professor
VA Puget Sound
Day One
Tuesday June 29 2021
3:30 pm | Live Q&A with Your Expert Speakers
3:00 pm | Exploring Mechanisms of SARS-CoV-2 Brain Entry: a Focus on the Blood-Brain Barrier
Carsten Hagemann
Head of the Tumorbiology Laboratory Department of Neurosurgery
University Hospital Wuerzburg
Day One
Tuesday June 29 2021
9:30 am | Leveraging Tumor Treating Fields (TTFields) to Overcome the BBB
Nathalie Cartier
Head of NeurogenCell Lab, Paris Brain Institute (ICM), INSERM, Paris Sorbonne University, CNS Expert
Asklepios BioPharmaceutical, Inc.
Day One
Tuesday June 29 2021
3:30 pm | Live Q&A with Your Expert Speakers
2:00 pm | Crossing the Blood-Brain Barrier to Improve CNS Gene Therapy: From Preclinical Models to Clinical Applications
Amber D. Van Laar
VP Clinical Development
Asklepios BioPharmaceutical, Inc.
Day One
Tuesday June 29 2021
3:30 pm | Live Q&A with Your Expert Speakers
2:30 pm | Overcoming the BBB with Direct CNS Delivery: Advantages and Challenges
William A. Banks
Associate Chief of Staff - Research & Development, VA Puget Sound Professor, Division of Gerontology & Geriatric Medicine, Department of Medicine
University of Washington